Elevance (ELV) just took a 12% hit after Q2 earnings missed estimates and full-year guidance was cut significantly. But here's the thing—the selloff may be overdone. The stock now trades at a forward P/E of ~10, well below industry peers, and is approaching multi-year support levels.
📥 Entry Plan :
✅ Entry 1: $302.45 (market price)
✅ Entry 2: $285 (historical support zone)
✅ Entry 3: $250 (capitulation panic level)
🎯 Target Levels:
TP1: $330 – recent gap zone + psychological resistance
TP2: $360 – key horizontal + potential MLR rebound narrative
TP3: $400 – longer-term recovery level, aligns with prior institutional range
🔔 Follow me for more deep-value setups, smart risk-reward trades, and weekly strategy posts!
⚠️ Disclaimer: This content is for informational and educational purposes only and does not constitute financial advice. I am not a financial advisor. Always do your own research and consult with a qualified professional before making any investment decisions. Trading and investing involve risk, including the potential loss of capital
📥 Entry Plan :
✅ Entry 1: $302.45 (market price)
✅ Entry 2: $285 (historical support zone)
✅ Entry 3: $250 (capitulation panic level)
🎯 Target Levels:
TP1: $330 – recent gap zone + psychological resistance
TP2: $360 – key horizontal + potential MLR rebound narrative
TP3: $400 – longer-term recovery level, aligns with prior institutional range
🔔 Follow me for more deep-value setups, smart risk-reward trades, and weekly strategy posts!
⚠️ Disclaimer: This content is for informational and educational purposes only and does not constitute financial advice. I am not a financial advisor. Always do your own research and consult with a qualified professional before making any investment decisions. Trading and investing involve risk, including the potential loss of capital
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.